Eylea® 8mg
Eylea® 2mg
Risk Minimizing Materials
OPHTHALMOLOGY
Bayer Israel
Eylea® 8mg
Eylea® 2mg
Risk Minimizing Materials
more_vert
Overview
nAMD
DME
RVO
Pre-Filled Syringe
Safety profile
Mechanism of action
Dosing
Resources
Overview
nAMD
DME
RVO
Pre-Filled Syringe
Safety profile
Mechanism of action
Dosing
Resources
Early Insights from Clinical Practice
Aflibercept 114.3mg/ml Main Studies in Age-Related Macular Degeneration (wAMD)
View
Aflibercept 114.3mg/ml Main Studies in Diabetic Macular Edema (DME)
View
